ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 151 filers reported holding PTC THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,079,000
-74.2%
17,678
-78.5%
0.00%
-75.0%
Q2 2020$4,181,000
-43.8%
82,400
-46.8%
0.01%
-52.9%
Q4 2019$7,443,000
+468.2%
154,969
+345.3%
0.02%
+466.7%
Q1 2019$1,310,000
+218.0%
34,800
+184.9%
0.00%
+200.0%
Q2 2018$412,000
-38.9%
12,214
-51.0%
0.00%
-50.0%
Q1 2018$674,00024,9220.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders